Based On The Analysis Of Earnings Report XHZY Financial Management Problems And Countermeasures

With the acceleration of global economic integration, China’s pharmaceutical manufacturing enterprises are facing more opportunities and challenges. The current ownership and management of listed companies has gradually achieve the separation, the role of financial management in the daily business activities of enterprises in the increasingly important, and the most basic of financial management, the most important job is on the company’s financial statements accurate and systematic research analysis. Business owners through financial statement analysis can identify problems and potential risks of the actual business operations, to find countermeasures, thus improving the optimization of enterprise management. Users outside the enterprise by looking at the financial statement analysis, to understand the financial position, cash flows and results of operations, and to assess the quality of corporate financial decision whether to invest.This study XHZY founded in 1943, is the focus of our large pharmaceutical listed companies, and enjoys a high reputation and influence in the pharmaceutical and chemical industry, the company’s development is relatively stable in recent years, in many product areas have always maintained industry leadership position. Articles in reference to the large number of domestic and international literature on earnings analysis and financial management, books, based on the XHZY company’s financial statements for the research and analysis object to financial management theory and academic knowledge as a guide, earnings analysis and financial management systematic study of the theory, common method earnings analysis and DuPont analysis system and so on. Comprehensive analysis of the financial statements of the company’s three XHZY five-year period 2009-2013, the comprehensive evaluation of the company in terms of debt service capacity, operations, profitability and development, etc., from a financial management perspective and then dig out the business operations found in the process of deep-seated problems, and the corresponding solutions and suggestions for improvement, provide a reference for business managers and investors.This paper presents the desired Solutions can help companies enhance their financial XHZY management level, to provide strong support for the company to continue to maintain rapid and healthy development stage and long-term sustainable development, while in 2009 the road again since China’s new medical reform, medical products The price and bidding policies, making the entire pharmaceutical industry began to face new challenges.XHZY company’s financial problems in the industry at this time a representative of the research and analysis, not only to provide suggestions and countermeasures in times of crisis, but also for other pharmaceutical companies in the industry can play a good reference.